Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial
Kathryn Coyle, Doug Coyle, Isabelle Nault, Ratika Parkash, Jeffrey S. Healey, Christopher J. Gray, Martin J. Gardner, Laurence D. Sterns, Vidal Essebag, Tomasz Hruczkowski, Louis Blier, George A. Wells, Anthony S.L. Tang, William G. Stevenson, John L. Sapp
Plonger dans les sujets de recherche 'Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial'. Ensemble, ils forment une empreinte numérique unique.